Streetwise Reports' Article Archives — August 2018 back to current month (14)

Drug Company Receives $5 Million Milestone Payment (08/31/2018)

Company entitled to receive quarterly earn-out payments from patent agreement.


Neurosciences Company Reports Potential for Improved Safety Profile for Alzheimer's Treatment (08/29/2018)

The substance shows potential for an improved safety profile in direct comparison to other Amyloid Beta-Directed Antibodies in clinical development.


Oncology-Focused Biotech Receives Orphan Status for AML Drug (08/29/2018)

An H.C. Wainwright & Co. report provided an update on two of this company's four product candidates.


Investor Opportunity Arises from Biopharma's Share Price Weakness on Competitor News (08/29/2018)

An analyst discussed the implications to this firm of a competitive product's advancement.


As Nitric Oxide Comes Off Patent, Lower-Cost Options for Life Saving Drug Becoming Possible (08/22/2018)

Dr. Ronald Day, a pediatric cardiologist at the University of Utah, has been using nitric oxide to treat children with pulmonary hypertension. Now, with a court ruling invalidating much of a drug patent for nitric oxide, lower-cost options might become available.


Coverage Initiated on Developer of Brachytherapy Products for Cancer Treatment (08/22/2018)

H.C. Wainwright & Co. analyst Jason Kolbert provided the rationale for investment in this company.


Biosciences Company Announces Research Collaboration for Testing Cannabis Ingredients (08/21/2018)

The development of analytic methods is a key milestone in the development of water-soluble cannabis technology.


Medical Device Firm Anticipates Benefit from Patent Ruling (08/15/2018)

This company, which develops delivery products for inhaled nitric oxide, a gas used to treat newborns with low oxygen levels and patients with COPD, sees opportunity in a newly invalidated patent.


Medical Device Firm's Clinical Programs Progress in Q2/18 (08/15/2018)

A Ladenburg Thalmann report reviewed the recent financial results for a California-based company that has developed treatments for vaginal laxity and female stress urinary incontinence.


Biotech Marks Progress on Programs for Cancer, Infectious Diseases (08/15/2018)

This firm, focused on immuno-oncology and infectious diseases including Ebola and Zika, is moving forward on a variety of fronts, according to a Maxim Group analyst.


Biopharma Signs Multimillion-Dollar Deal for Key Products in China (08/08/2018)

An H.C. Wainwright & Co. report reviewed the arrangement.


U.S. Medical Device Firm Pursues ISO 13485 Certification (08/01/2018)

With this move, this company aims for fast-tracked regulatory approval for its nitric oxide delivery system.


Cash Stream from Licensing Deal to Help Biopharma Advance Lead Drug (08/01/2018)

A Laidlaw & Co. report discussed this firm's revenue and near-term, clinical catalysts.


Biotech Releases White Paper on Alzheimer's Disease Candidate (08/01/2018)

A company focused on treatment of neurodegenerative diseases has issued a white paper discussing its lead candidate.


More Archives


2023Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2022Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2021Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2020Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2019Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

Get Our Streetwise Reports' Life Sciences Report Newsletter Free and be the first to know!

A valid email address is required to subscribe

Notable Quotes